Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

High extinction risk for wild coffee species and implications for coffee sector sustainability.

Davis AP, Chadburn H, Moat J, O'Sullivan R, Hargreaves S, Nic Lughadha E.

Sci Adv. 2019 Jan 16;5(1):eaav3473. doi: 10.1126/sciadv.aav3473. eCollection 2019 Jan.

2.

The UCL-Lancet Commission on Migration and Health: the health of a world on the move.

Abubakar I, Aldridge RW, Devakumar D, Orcutt M, Burns R, Barreto ML, Dhavan P, Fouad FM, Groce N, Guo Y, Hargreaves S, Knipper M, Miranda JJ, Madise N, Kumar B, Mosca D, McGovern T, Rubenstein L, Sammonds P, Sawyer SM, Sheikh K, Tollman S, Spiegel P, Zimmerman C; UCL–Lancet Commission on Migration and Health.

Lancet. 2018 Dec 15;392(10164):2606-2654. doi: 10.1016/S0140-6736(18)32114-7. Epub 2018 Dec 5. Review. No abstract available.

PMID:
30528486
3.

Global patterns of mortality in international migrants: a systematic review and meta-analysis.

Aldridge RW, Nellums LB, Bartlett S, Barr AL, Patel P, Burns R, Hargreaves S, Miranda JJ, Tollman S, Friedland JS, Abubakar I.

Lancet. 2018 Dec 15;392(10164):2553-2566. doi: 10.1016/S0140-6736(18)32781-8. Epub 2018 Dec 5.

4.

Health impacts of parental migration on left-behind children and adolescents: a systematic review and meta-analysis.

Fellmeth G, Rose-Clarke K, Zhao C, Busert LK, Zheng Y, Massazza A, Sonmez H, Eder B, Blewitt A, Lertgrai W, Orcutt M, Ricci K, Mohamed-Ahmed O, Burns R, Knipe D, Hargreaves S, Hesketh T, Opondo C, Devakumar D.

Lancet. 2018 Dec 15;392(10164):2567-2582. doi: 10.1016/S0140-6736(18)32558-3. Epub 2018 Dec 5.

5.

The use and misuse of herbarium specimens in evaluating plant extinction risks.

Nic Lughadha E, Walker BE, Canteiro C, Chadburn H, Davis AP, Hargreaves S, Lucas EJ, Schuiteman A, Williams E, Bachman SP, Baines D, Barker A, Budden AP, Carretero J, Clarkson JJ, Roberts A, Rivers MC.

Philos Trans R Soc Lond B Biol Sci. 2018 Nov 19;374(1763). pii: 20170402. doi: 10.1098/rstb.2017.0402. Review.

6.

National approaches to the vaccination of recently arrived migrants in Europe: A comparative policy analysis across 32 European countries.

Ravensbergen SJ, Nellums LB, Hargreaves S, Stienstra Y, Friedland JS; ESGITM Working Group on Vaccination in Migrants.

Travel Med Infect Dis. 2019 Jan - Feb;27:33-38. doi: 10.1016/j.tmaid.2018.10.011. Epub 2018 Oct 16.

7.

Divergent approaches in the vaccination of recently arrived migrants to Europe: a survey of national experts from 32 countries, 2017.

Hargreaves S, Nellums LB, Ravensbergen SJ, Friedland JS, Stienstra Y, On Behalf Of The Esgitm Working Group On Vaccination In Migrants.

Euro Surveill. 2018 Oct;23(41). doi: 10.2807/1560-7917.ES.2018.23.41.1700772.

8.

Migrant and refugee populations: a public health and policy perspective on a continuing global crisis.

Abbas M, Aloudat T, Bartolomei J, Carballo M, Durieux-Paillard S, Gabus L, Jablonka A, Jackson Y, Kaojaroen K, Koch D, Martinez E, Mendelson M, Petrova-Benedict R, Tsiodras S, Christie D, Saam M, Hargreaves S, Pittet D.

Antimicrob Resist Infect Control. 2018 Sep 20;7:113. doi: 10.1186/s13756-018-0403-4. eCollection 2018. Review.

9.

Interventions to Improve Vaccination Uptake and Cost Effectiveness of Vaccination Strategies in Newly Arrived Migrants in the EU/EEA: A Systematic Review.

Hui C, Dunn J, Morton R, Staub LP, Tran A, Hargreaves S, Greenaway C, Biggs BA, Christensen R, Pottie K.

Int J Environ Res Public Health. 2018 Sep 20;15(10). pii: E2065. doi: 10.3390/ijerph15102065.

10.

Forecasting the global demand for HIV monitoring and diagnostic tests: A 2016-2021 analysis.

Habiyambere V, Dongmo Nguimfack B, Vojnov L, Ford N, Stover J, Hasek L, Maggiore P, Low-Beer D, Pérez Gonzàlez M, Edgil D, Williams J, Kuritsky J, Hargreaves S, NeSmith T.

PLoS One. 2018 Sep 19;13(9):e0201341. doi: 10.1371/journal.pone.0201341. eCollection 2018.

11.

Antimicrobial resistance among migrants in Europe - Authors' reply.

Nellums LB, Friedland JS, Hargreaves S.

Lancet Infect Dis. 2018 Sep;18(9):945. doi: 10.1016/S1473-3099(18)30495-X. No abstract available. Erratum in: Lancet Infect Dis. 2018 Oct;18(10):1063.

PMID:
30152357
12.
13.

Linkage to Care Is Important and Necessary When Identifying Infections in Migrants.

Pareek M, Noori T, Hargreaves S, van den Muijsenbergh M.

Int J Environ Res Public Health. 2018 Jul 22;15(7). pii: E1550. doi: 10.3390/ijerph15071550.

14.
15.

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis.

Nellums LB, Thompson H, Holmes A, Castro-Sánchez E, Otter JA, Norredam M, Friedland JS, Hargreaves S.

Lancet Infect Dis. 2018 Jul;18(7):796-811. doi: 10.1016/S1473-3099(18)30219-6. Epub 2018 May 17.

16.

How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review.

Seedat F, Hargreaves S, Nellums LB, Ouyang J, Brown M, Friedland JS.

Lancet Infect Dis. 2018 Sep;18(9):e259-e271. doi: 10.1016/S1473-3099(18)30117-8. Epub 2018 May 16. Review.

17.

Catalysing the development and introduction of paediatric drug formulations for children living with HIV: a new global collaborative framework for action.

Penazzato M, Watkins M, Morin S, Lewis L, Pascual F, Vicari M, Lee J, Hargreaves S, Doherty M, Siberry GK.

Lancet HIV. 2018 May;5(5):e259-e264. doi: 10.1016/S2352-3018(18)30005-5. Epub 2018 May 1.

PMID:
29739700
18.

Who is responsible for the vaccination of migrants in Europe?

Hargreaves S, Nellums LB, Ramsay M, Saliba V, Majeed A, Mounier-Jack S, Friedland JS.

Lancet. 2018 May 5;391(10132):1752-1754. doi: 10.1016/S0140-6736(18)30846-8. No abstract available.

19.

Communities in charge of alcohol (CICA): a protocol for a stepped-wedge randomised control trial of an alcohol health champions programme.

Cook PA, Hargreaves SC, Burns EJ, de Vocht F, Parrott S, Coffey M, Audrey S, Ure C, Duffy P, Ottiwell D, Kenth K, Hare S, Ardern K.

BMC Public Health. 2018 Apr 19;18(1):522. doi: 10.1186/s12889-018-5410-0.

20.

Vaccination status and needs of asylum-seeking children in Denmark: a retrospective data analysis.

Nakken CS, Skovdal M, Nellums LB, Friedland JS, Hargreaves S, Norredam M.

Public Health. 2018 May;158:110-116. doi: 10.1016/j.puhe.2018.02.018. Epub 2018 Apr 10.

21.

Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis.

Nellums LB, Rustage K, Hargreaves S, Friedland JS.

BMC Med. 2018 Feb 22;16(1):27. doi: 10.1186/s12916-017-1001-7. Review.

22.

Safeguarding health in Europe's migrant hotspots.

Hargreaves S.

Lancet Infect Dis. 2017 Jul;17(7):698. doi: 10.1016/S1473-3099(17)30350-X. Epub 2017 Jun 21. No abstract available.

PMID:
28737491
23.

Differences in soil biological activity by terrain types at the sub-field scale in central Iowa US.

Kaleita AL, Schott LR, Hargreaves SK, Hofmockel KS.

PLoS One. 2017 Jul 7;12(7):e0180596. doi: 10.1371/journal.pone.0180596. eCollection 2017.

24.
25.

The role of pre-migration medical screening in high TB burden countries.

Hargreaves S, Duarte R, Friedland JS.

Int J Tuberc Lung Dis. 2017 Jul 1;21(7):718-719. doi: 10.5588/ijtld.17.0317. No abstract available.

PMID:
28633693
26.

Community acquired infections among refugees leading to Intensive Care Unit admissions in Turkey.

Turktan M, Ak O, Erdem H, Ozcengiz D, Hargreaves S, Kaya S, Karakoc E, Ozkan-Kuscu O, Tuncer-Ertem G, Tekin R, Birbicer H, Durmus G, Yilmaz C, Kocak F, Puca E, Rello J.

Int J Infect Dis. 2017 May;58:111-114. doi: 10.1016/j.ijid.2017.02.022. Epub 2017 Apr 15.

27.

The burden and epidemiology of community-acquired central nervous system infections: a multinational study.

Erdem H, Inan A, Guven E, Hargreaves S, Larsen L, Shehata G, Pernicova E, Khan E, Bastakova L, Namani S, Harxhi A, Roganovic T, Lakatos B, Uysal S, Sipahi OR, Crisan A, Miftode E, Stebel R, Jegorovic B, Fehér Z, Jekkel C, Pandak N, Moravveji A, Yilmaz H, Khalifa A, Musabak U, Yilmaz S, Jouhar A, Oztoprak N, Argemi X, Baldeyrou M, Bellaud G, Moroti RV, Hasbun R, Salazar L, Tekin R, Canestri A, Čalkić L, Praticò L, Yilmaz-Karadag F, Santos L, Pinto A, Kaptan F, Bossi P, Aron J, Duissenova A, Shopayeva G, Utaganov B, Grgic S, Ersoz G, Wu AKL, Lung KC, Bruzsa A, Radic LB, Kahraman H, Momen-Heravi M, Kulzhanova S, Rigo F, Konkayeva M, Smagulova Z, Tang T, Chan P, Ahmetagic S, Porobic-Jahic H, Moradi F, Kaya S, Cag Y, Bohr A, Artuk C, Celik I, Amsilli M, Gul HC, Cascio A, Lanzafame M, Nassar M.

Eur J Clin Microbiol Infect Dis. 2017 Sep;36(9):1595-1611. doi: 10.1007/s10096-017-2973-0. Epub 2017 Apr 10.

PMID:
28397100
28.

Response to Letter to the Editor by M. van der Werf, V. Hollo and C. Ködmön concerning 'Multidrug-resistant tuberculosis and migration to Europe'.

Hargreaves S, Lönnroth K, Nellums LB, Olaru ID, Nathavitharana RR, Norredam M, Friedland JS.

Clin Microbiol Infect. 2017 Aug;23(8):580. doi: 10.1016/j.cmi.2017.02.022. Epub 2017 Feb 28. No abstract available.

29.

Evolving migrant crisis in Europe: implications for health systems.

Carballo M, Hargreaves S, Gudumac I, Maclean EC.

Lancet Glob Health. 2017 Mar;5(3):e252-e253. doi: 10.1016/S2214-109X(17)30040-2. No abstract available.

30.

Multidrug-resistant tuberculosis and migration to Europe.

Hargreaves S, Lönnroth K, Nellums LB, Olaru ID, Nathavitharana RR, Norredam M, Friedland JS.

Clin Microbiol Infect. 2017 Mar;23(3):141-146. doi: 10.1016/j.cmi.2016.09.009. Epub 2016 Sep 23. Review.

31.

Time to rethink approaches to migrant health screening.

Hargreaves S, Nellums L, Friedland JS.

Lancet. 2016 Nov 19;388(10059):2456-2457. doi: 10.1016/S0140-6736(16)31703-2. Epub 2016 Oct 11. No abstract available.

32.

Concerns in Turkey about infections from refugees.

Hargreaves S.

Lancet Infect Dis. 2016 Jul;16(7):782-783. doi: 10.1016/S1473-3099(15)00310-2. No abstract available.

PMID:
27352760
33.

Stereotactic Ablative Radiotherapy for Oligometastatic Disease: a Treatment in Search of Evidence - a Response.

Hargreaves S, Comins C.

Clin Oncol (R Coll Radiol). 2016 Aug;28(8):503-4. doi: 10.1016/j.clon.2016.04.049. Epub 2016 May 30. No abstract available.

PMID:
27251441
34.

Infections in travellers returning to Turkey from the Arabian peninsula: a retrospective cross-sectional multicenter study.

Erdem H, Ak O, Elaldi N, Demirdal T, Hargreaves S, Nemli SA, Cag Y, Ulug M, Naz H, Gunal O, Sirmatel F, Sipahi OR, Alpat SN, Ertem-Tuncer G, Sozen H, Evlice O, Meric-Koc M, Dogru A, Koksaldi-Motor V, Tekin R, Ozdemir D, Ozturk-Engin D, Savasci U, Karagoz E, Cekli Y, Inan A.

Eur J Clin Microbiol Infect Dis. 2016 Jun;35(6):903-10. doi: 10.1007/s10096-016-2614-z. Epub 2016 Mar 10.

PMID:
26964538
35.

Extending migrant charging into emergency services.

Hargreaves S, Nellums L, Friedland JS, Goldberg J, Murwill P, Jones L.

BMJ. 2016 Feb 9;352:i685. doi: 10.1136/bmj.i685. No abstract available.

PMID:
26861212
36.

Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges.

Roberts T, Cohn J, Bonner K, Hargreaves S.

Clin Infect Dis. 2016 Apr 15;62(8):1043-8. doi: 10.1093/cid/ciw001. Epub 2016 Jan 6.

37.

Europe's migrants face unacceptable humanitarian situation.

Hargreaves S.

Lancet Infect Dis. 2016 Jan;16(1):27-28. doi: 10.1016/S1473-3099(15)00495-8. No abstract available.

PMID:
26738836
38.

Listening to parents to improve health visiting practice.

Morton A, Hargreaves S, Taylor L.

Community Pract. 2015 May;88(5):30-3, 35.

PMID:
26364334
39.

Environmental Filtering of Microbial Communities in Agricultural Soil Shifts with Crop Growth.

Hargreaves SK, Williams RJ, Hofmockel KS.

PLoS One. 2015 Jul 30;10(7):e0134345. doi: 10.1371/journal.pone.0134345. eCollection 2015.

40.

Screening for latent TB, HIV, and hepatitis B/C in new migrants in a high prevalence area of London, UK: a cross-sectional study.

Hargreaves S, Seedat F, Car J, Escombe R, Hasan S, Eliahoo J, Friedland JS.

BMC Infect Dis. 2014 Dec 3;14:657. doi: 10.1186/s12879-014-0657-2.

41.

Engaging new migrants in infectious disease screening: a qualitative semi-structured interview study of UK migrant community health-care leads.

Seedat F, Hargreaves S, Friedland JS.

PLoS One. 2014 Oct 15;9(10):e108261. doi: 10.1371/journal.pone.0108261. eCollection 2014.

42.

Educational supervision for GP trainees: 'feeding the beast'?

Holden J, Cox S, Breach M, Hargreaves S, van Dessel M, Hyde S, White J, Parr H, Clarke C.

Educ Prim Care. 2013 Jul;24(4):297. No abstract available.

PMID:
23906174
43.

Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom.

Palmer DH, Hussain SA, Smith AJ, Hargreaves S, Ma YT, Hull D, Johnson PJ, Ross PJ.

Br J Cancer. 2013 Aug 20;109(4):888-90. doi: 10.1038/bjc.2013.410. Epub 2013 Jul 23.

44.

Tuberculosis 2013 series.

McConnell J, Hargreaves S.

Lancet Infect Dis. 2013 Apr;13(4):284-5. doi: 10.1016/S1473-3099(13)70077-X. Epub 2013 Mar 24. No abstract available.

PMID:
23531384
45.

Revalidation: helping leaders to promote insight and avoid isolation.

Holden JD, Cox SJ, Hargreaves SA.

Educ Prim Care. 2013 Jan;24(1):19-21. No abstract available.

PMID:
23356758
46.

Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis.

Shubber Z, Calmy A, Andrieux-Meyer I, Vitoria M, Renaud-Théry F, Shaffer N, Hargreaves S, Mills EJ, Ford N.

AIDS. 2013 Jun 1;27(9):1403-12. doi: 10.1097/QAD.0b013e32835f1db0. Review.

PMID:
23343913
47.

Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis.

Ford N, Calmy A, Andrieux-Meyer I, Hargreaves S, Mills EJ, Shubber Z.

AIDS. 2013 Apr 24;27(7):1135-43. doi: 10.1097/QAD.0b013e32835e0752. Review.

PMID:
23299174
48.

Service provision. What's the alternative?

Holden J, Hargreaves S, van Dessel M, Bonney J.

Health Serv J. 2012 Sep 27;122(6322):32-3. No abstract available.

PMID:
23234063
49.

Mortality after fluid bolus in children with shock due to sepsis or severe infection: a systematic review and meta-analysis.

Ford N, Hargreaves S, Shanks L.

PLoS One. 2012;7(8):e43953. doi: 10.1371/journal.pone.0043953. Epub 2012 Aug 30. Review.

50.

New research and development strategy for tuberculosis diagnostics urgently needed.

Batz HG, Casenghi M, Cooke GS, Hargreaves S, Reid SD, Syed J.

Lancet Infect Dis. 2012 Aug;12(8):584-5. doi: 10.1016/S1473-3099(12)70166-4. No abstract available.

PMID:
22835891

Supplemental Content

Loading ...
Support Center